Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Gilead Asks Supreme Court To Restrict False Claims Act Cases

Jan 08 2018

• By Brenda Sandburg

US Supreme Court building facade with words Equal Justice

Related Content

Copay Kickback Enforcement Gains Momentum: United Therapeutics Settles Charges

Dec 27 2017

Novo's Victoza REMS Settlement Opens Another Legal Door For Off-Label Promotion Cases

Sep 07 2017

Mylan Communications With CMS To Get Outside Review Under EpiPen Settlement

Aug 17 2017

Pfizer Protonix Settlement May Deter Price Bundling

Feb 16 2016

Aegerion <em>Juxtapid</em> Settlement Shows REMS Have Teeth: Alternate Route To Enforce Off-Label?

May 23 2016

Related Companies

Gilead Sciences, Inc.

Genentech, Inc.

Amgen, Inc.

Pfizer Inc.

Wyeth

Viatris Inc.

Novo Nordisk A/S

Aegerion Pharmaceuticals, Inc.

Additional Topics

United States Legal Issues Government Payers Policy Reimbursement FDA BioPharmaceutical

More from Legal & IP

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window